SmPC - Piroxicam Capsules 20mg: Change history
View Summary of Product Characteristics (SmPC - Piroxicam Capsules 20mg)
Last updated on this site: 02 Dec 2024
To update sections 4.8 and 4.9 of the SPC in line with the reference product Feldene 20mg Capsules (PL 00057/0146; MAH: Pfizer Limited). Consequently, the PIL has been updated.
Last updated on this site: 02 Dec 2024
To update sections 4.8 and 4.9 of the SPC in line with the reference product Feldene 20mg Capsules (PL 00057/0146; MAH: Pfizer Limited). Consequently, the PIL has been updated.
-
Changes: (Updated: 02 Dec 2024)
To update sections 4.8 and 4.9 of the SPC in line with the reference product Feldene 20mg Capsules (PL 00057/0146; MAH: Pfizer Limited). Consequently, the PIL has been updated.
-
Changes: (Updated: 08 Feb 2023)
Variation Description: To register an update to sections 4.6 of the SmPC in line with PRAC recommendation (EMA/CMDh/642745/2022: NSAID-containing medicinal products (for systemic use) and use during pregnancy). Consequently, the leaflet has been updated.
SmPC sections updated – 4.6 and 10.
-
Changes: (Updated: 21 Sep 2022)
Initial upload